Clinical Laserthermia Systems AB enters into top down underwriting commitments in the ongoing exercise of warrants of series TO 6 B totaling SEK 7 million.
Lund, Sweden - Clinical Laserthermia Systems AB ("CLS" or the "Company") announces that the Company has agreed on underwriting commitments (so-called "top-down" or "top guarantee") in the ongoing exercise of warrants of series TO 6 B whose exercise period runs until February 6, 2024 ("TO 6 B"). The underwriting commitments comprises a total of SEK 7 million, corresponding to approximately 30 per cent of the issue proceeds that the Company can raise through the exercise of TO 6 B.In the ongoing exercise of TO 6 B, CLS has agreed on top down underwriting commitments with qualified investors.